Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
BridgeBio Oncology Therapeutics reported a net loss of $34.2 million for the third quarter of 2026, an improvement from the $44.8 million loss in the prior year period. Total assets decreased to $346.2 million from $448.4 million at year-end 2025, primarily driven by a significant reduction in cash and cash equivalents as the company continues to fund its research and development operations.
Airgain, Inc. reported sales of $15.3 million for the third quarter of 2026, a 9.3% increase compared to the same period in 2025. The company narrowed its net loss to $0.6 million for the quarter, down from a $1.0 million loss in the prior year, driven by higher gross profit and reduced operating expenses.
Sportradar Group CAO James Scott Ritter Sells $44.9K of Stock
James Scott Ritter, CAO, sold 3,500 shares of Sportradar Group AG at $12.83 a share, worth $44.9K in total on Aug 28, 2026. Shares held after the trade: 37,113 (-8.6%).
Artisan Partners Asset Management reported preliminary assets under management (AUM) of $167.8 billion as of October 31, 2026. The firm's AUM is diversified across several investment teams, with the International Value Group and Global Value Team representing the largest portions at $58.7 billion and $33.0 billion respectively.
Asana $150M Debt Financing with Wells Fargo Bank, National Association
Asana, Inc. entered into a new $150 million senior secured revolving credit facility with Wells Fargo and MUFG Bank. The facility includes sub-limits for letters of credit and swingline loans and matures on November 9, 2031. The funds are intended for working capital and general corporate purposes, though no amounts were drawn at closing.
Amkor Technology President and CEO Kevin K. Engel Sells $35K of Stock
Kevin K. Engel, President and CEO, sold 1,000 shares of Amkor Technology, Inc. at $35.00 a share, worth $35K in total on Nov 9, 2026. Shares held after the trade: 8,666 (-10.3%).
Crown Castle VP and Controller Robert Sean Collins Sells $222K of Stock
Robert Sean Collins, VP and Controller, sold 2,500 shares of Crown Castle Inc. at $88.87 a share, worth $222K in total on Nov 6, 2026. Shares held after the trade: 2,613 (-48.9%).
Vertex Pharmaceuticals CEO & President Reshma Kewalramani Sells $6.31M of Stock
Reshma Kewalramani, CEO & President, sold 11,866 shares of Vertex Pharmaceuticals Inc at $531.53 a share, worth $6.31M in total on Nov 6, 2026. Shares held after the trade: 86,471 (-12.1%).
Marchex reported third quarter 2026 financial results, returning to revenue growth and GAAP profitability with $16.0 million in revenue and $1.3 million in net income. The company highlighted commercial momentum following its Archenia acquisition, including the expansion of AI Voice Agent deployments and automotive OEM distribution. Additionally, Travis Fairchild was appointed as President of the company.
Term
Q3 2026
“Our third quarter results reflect a new phase of growth and meaningful progress in strengthening Marchex's financial performance, with year-over-year revenue growth, positive GAAP net income, and a significant improvement in Adjusted EBITDA.”
Russell Horowitz, Chairman of Marchex
“By bringing together Marchex's conversational intelligence and analytics with Archenia's AI-powered customer qualification and acquisition technologies, we are creating a differentiated platform that connects customer insights with automated actions and measurable business outcomes.”
Darren S. Raiguel, COO, sold 1,896 shares of Eplus Inc at $91.37 to $96.02 a share (average $93.12) in 5 transactions, worth $177K in total between Nov 6, 2026 and Nov 9, 2026. Shares held after the trade: 65,036 (-0.2%).
Lincoln National EVP, GC & Chief Gov Officer CraigT T. Beazer Sells $764K of Stock
CraigT T. Beazer, EVP, GC & Chief Gov Officer, sold 17,980 shares of Lincoln National Corp at $42.50 a share, worth $764K in total on Nov 9, 2026. Shares held after the trade: 87,702 (-17.0%).
Astronics Corporation reported record third quarter 2026 financial results, with sales growing 28.5% to $271.7 million and record operating income of $54.0 million. The company achieved a book-to-bill ratio of 1.00 and maintained its full-year 2026 revenue guidance of $1.02 billion to $1.04 billion.
“We delivered a strong third quarter, with record sales and operating income and an adjusted EBITDA margin near its all-time high. These results reflect disciplined operational execution and strong demand across our markets. Bookings were a solid $271.1 million following the prior quarter that had benefited from a couple of large program awards. We expect momentum to continue as we head into the final quarter of the year.”
Peter J. Gundermann, Chairman, President and Chief Executive Officer
Liberty Latin America Insider John C. Malone Buys $221K of Stock
John C. Malone bought 11,017 shares of Liberty Latin America Ltd. at $20.08 a share, worth $221K in total on Nov 6, 2026. Shares held after the trade: 3,057.
GoPro filed a notification of late filing for its Q3 2026 Form 10-Q due to ongoing material weaknesses in internal controls over the valuation of financing arrangements. The company is also actively seeking waivers from lenders for covenant noncompliance that could otherwise trigger an event of default and debt acceleration.
HawkEye 360 appointed former CIA Director Ambassador William J. Burns to its Board of Directors as a Class II director. Ambassador Burns will receive an annual cash retainer of $50,000 and an initial one-time grant of restricted stock units valued at $400,000. His appointment brings significant national security and diplomatic expertise to the company as it expands its signals intelligence capabilities for defense and intelligence missions.
This filing contains a Section 13(r) disclosure regarding a minority non-controlling interest in Malaysia Airports Holdings Berhad held by BlackRock affiliates. The disclosure reports that Iran Airtour resumed flight operations to one of the airports operated by Malaysia Airports Holdings Berhad starting in August 2026.
BridgeBio Oncology Therapeutics reported financial results for the third quarter of 2026, highlighting a cash runway expected to fund operations into 2029. The company reported clinical progress for its RAS-pathway inhibitors, including a 75% objective response rate for BBO-8520 in combination with pembrolizumab in certain lung cancer patients. Management expects monotherapy data updates for BBO-11818 and BBO-10203 in the fourth quarter of 2026.
Term
Q3 2026
“The third quarter was an important period for BBOT as we reported updated clinical data for BBO-8520 and delineated our strategic focus. Driven by encouraging clinical data across all three programs we are executing on multiple combinations with the potential for significant patient benefit.”
Pedro J. Beltran, Ph.D., Chief Executive Officer of BBOT
“With a strong balance sheet, multiple data catalysts expected through mid-2027, and cash runway into 2029, we believe BBOT is well positioned to advance differentiated therapies for patients with KRAS-driven cancers.”
Pedro J. Beltran, Ph.D., Chief Executive Officer of BBOT
Copper Property CTL Pass Through Trust reported net income of $12.99 million for the quarter ended September 30, 2026, a significant increase from $1.29 million in the prior year period, primarily due to the absence of a $10.67 million impairment charge recorded in 2025. The Trust's real estate portfolio consists of 117 retail properties, and it is currently in the process of extending its termination date to January 5, 2027.
Keel Infrastructure Insider Edith Hofmeister Buys $28.4K of Stock
Edith Hofmeister bought 15,000 shares of Keel Infrastructure Corp. at $1.89 a share, worth $28.4K in total on Nov 9, 2026. Shares held after the trade: 255,001 (+6.2%).
New Mountain Guardian IV BDC, L.L.C. disclosed its portfolio composition by sub-industry as of September 30, 2026. The filing provides a detailed breakdown of its investments, with Business Services (34.8%) and Software (29.3%) representing the largest concentrations of the portfolio at fair value.
FactSet hosted an Investor Day in New York City to detail its strategic vision and medium-term outlook through fiscal 2029. The company reaffirmed its fiscal 2027 guidance and introduced a new financial algorithm targeting an organic revenue CAGR of approximately 6% and an adjusted operating margin of at least 36% by fiscal 2029.
Term
through fiscal 2029
“FactSet has a generational opportunity to become the world’s most trusted financial intelligence platform and create long-term shareholder value. Our strategy to deliver connected data, advanced analytics, and intelligent workflows positions us well to provide trusted AI and expand its use at our clients based on our strong quality, cost, and control value proposition.”
Sanoke Viswanathan, Chief Executive Officer of FactSet
Rachel Silverstein has stepped down from her role as EVP, General Counsel and Corporate Secretary of Keel Infrastructure Corp., effective November 4, 2026. The company did not name an immediate successor for the position in the filing.
PetMed Express reported second quarter fiscal year 2027 net sales of $35.8 million, a 19.4% decrease year-over-year driven by lower prescription sales. The company narrowed its net loss to $6.4 million compared to $8.5 million in the prior year, aided by reduced general, administrative, and advertising expenses. CEO Jeff Willard noted the company is focused on stabilizing operations and reducing customer acquisition costs, which fell 32% from the previous year.
Term
Q2 2027
“We have stabilized the operations of the business and our focus now is on transforming our core direct-to-consumer pharmacy business and making PetMeds a leaner, more profitable company at the size we are today.”
Jeff Willard, Chief Executive Officer and President of PetMeds
“We are already making progress: this quarter we cut our cost to acquire a new customer by 32% from a year ago. Next, we are repositioning the brand so pet parents know exactly why to choose PetMeds, making our marketing work harder, making our website easier to buy from, and keeping more of the customers we win.”
Jeff Willard, Chief Executive Officer and President of PetMeds
Everest Group Insider William F. Galtney Jr. Sells $1.04M of Stock
William F. Galtney Jr. sold 2,500 shares of Everest Group, Ltd. at $414.29 a share, worth $1.04M in total on Nov 10, 2026. Shares held after the trade: 37,991 (-6.2%).
Skyworks Solutions reported higher operating expenses in fiscal 2026 due to a weakening U.S. dollar against the Mexican Peso and the enactment of the One Big Beautiful Bill Act (OBBBA). The company also completed a significant acquisition of Qorvo on October 5, 2026, which is expected to increase the complexity of its global tax profile and potential tax liabilities.
ARMOUR Residential REIT announced that management will meet with investors at the Citizens Financial Services Conference on November 17, 2026, and has published an updated investor presentation. The company also provided an updated estimate of its book value per common share, ranging from $15.52 to $15.62 as of November 9, 2026.
RideNow Group reported a net loss of $13.9 million for the third quarter of 2026, compared to a $4.1 million loss in the prior year, driven by lower powersports vehicle revenue and a $5.7 million loss on debt extinguishment. The company transitioned to a single-segment operation following the cessation of its vehicle transportation services business in late 2025.
Timothy I. McGuire notified Dollar General Corporation of his decision to resign from the Board of Directors for personal reasons, effective December 3, 2026. The company stated the resignation is not due to any disagreement regarding operations, policies, or practices.
National Healthcare Properties Divestiture for $531M
National Healthcare Properties is filing pro forma financial information regarding its probable $531.4 million sale of a 40-facility outpatient medical portfolio to an unaffiliated third party. The filing also accounts for the aggregate impact of 24 completed and 8 probable acquisitions of senior housing operating portfolio (SHOP) communities. The divestiture is expected to close in the fourth quarter of 2026.
Invesco Ltd. reported preliminary assets under management (AUM) of $2,453.5 billion for the month ended October 31, 2026, representing a 3.3% decrease from the prior month. The decline was primarily driven by $51 billion in unfavorable market returns and $32.9 billion in money market net outflows, partially offset by a slight increase from foreign exchange impact.